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Abstract
Parkinson's disease (PD) is a neurodegenerative condition of unknown etiology. This article is
devoted to special genotoxicological testing of a new substance with antiparkinsonian activity. It
was assessed using Allium cepa-test system. As a result of study of the effect (1R, 2R, 6S)--
-methyl-6-(prop-1-en-2-yl) cyclohex-3-ene-1,2-diol in cell model object (Allium cepa) we revealed
two distinctive  features  of  the  effects  of  substance-itotoxic  effect  and no  increase  in  the
frequency of genetic disorders with increasing concentration of the substance. In general, the
tested substance seems safe. © IDOSI Publications, 2013.
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